Anti-tumor potency of cancer vaccine ONCOS-102 in the treatment of malignant mesothelioma in pre-clinical and clinical studies

Kuryk L.; Ranki T.; Pesonen S.; Hemminki A.; Backman C.; von Euler M.; Jager E.; Karbach J.; Wahl C.; Joensuu T.; Kairemo K.; Alank T.; Partanen K.; Haavisto E.; Hakonen T.; Heiskanen R.; Juhila J.; Priha P.; Suoranta L.; Vassilev L.; Garofalo M.; Capasso C.; Hirvinen M.; Cerullo V.; Vuolanto A.; Jaderberg M.

首页> 外文期刊>Human gene therapy >Anti-tumor potency of cancer vaccine ONCOS-102 in the treatment of malignant mesothelioma in pre-clinical and clinical studies

【24h】

Anti-tumor potency of cancer vaccine ONCOS-102 in the treatment of malignant mesothelioma in pre-clinical and clinical studies

机译：临床前和临床研究中的癌症疫苗ONCOS-102在治疗恶性间皮瘤中的抗肿瘤效力

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Human gene therapy》 |2016年第11期|共2页
作者
Kuryk L.; Ranki T.; Pesonen S.; Hemminki A.; Backman C.; von Euler M.; Jager E.; Karbach J.; Wahl C.; Joensuu T.; Kairemo K.; Alank T.; Partanen K.; Haavisto E.; Hakonen T.; Heiskanen R.; Juhila J.; Priha P.; Suoranta L.; Vassilev L.; Garofalo M.; Capasso C.; Hirvinen M.; Cerullo V.; Vuolanto A.; Jaderberg M.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类治疗学;
关键词

相似文献

外文文献
中文文献
专利

1. Anti-tumor potency of cancer vaccine ONCOS-102 in the treatment of malignant mesothelioma in pre-clinical and clinical studies [J] . Kuryk L., Ranki T., Pesonen S., Human gene therapy . 2016,第11期

机译：临床前和临床研究中的癌症疫苗ONCOS-102在治疗恶性间皮瘤中的抗肿瘤效力
2. Phase II study of first-line bortezomib and cisplatin in malignant pleural mesothelioma and prospective validation of progression free survival rate as a primary end-point for mesothelioma clinical trials (European Organisation for Research and Treatment of Cancer 08052) [J] . OBrienM.E.R., GaafarR.M., PopatS., European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR) . 2013,第13期

机译：硼替佐米和顺铂一线用于恶性胸膜间皮瘤的II期研究和无进展生存率的前瞻性验证是间皮瘤临床试验的主要终点（欧洲癌症研究与治疗组织08052）
3. P1.09-012 A Pre-Clinical Investigation of Intrapleural Curcumin Treatments as an Adjunct Therapy for Malignant Pleural Mesothelioma [J] . A. Hocking, D. Elliot, J. Hua, Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer . 2017,第11期

机译：P1.09-012胸腔内姜黄素治疗作为恶性胸腔间皮瘤的辅助治疗的临床前调查
4. STUDY OF SURGICAL TREATMENT OF ORAL MALIGNANT MELANOMA AND THERAPEUTIC ANTI-CANCER VACCINE AUTOLOGOUS IN DOGS. [C] . Claudia Felizzola, Suzana Souza Annual Conference of the Veterinary Cancer Society . 2009

机译：犬口腔恶性黑素瘤和治疗抗癌疫苗的外科治疗研究。
5. Clinical predictive value of pre-clinical cancer models: A study of the predictive value of the in vitro cell line, human xenograft and murine allograft pre-clinical cancer models for phase II clinical trials of cytotoxic cancer drugs [D] . Voskoglou-Nomikos, Theodora 2001

机译：临床前癌症模型的临床预测价值：体外细胞系，人异种移植和小鼠同种异体移植临床前癌症模型对细胞毒性癌症药物II期临床试验的预测价值研究
6. Pre-clinical testing of malignant fibroblast activation protein-specific re-directed T cells for treatment of pleural mesothelioma [O] . Petra C Schuberth, Christian Hagedorn, Shawn M Jensen, 2013

机译：恶性成纤维细胞活化蛋白特异性重定向T细胞治疗胸膜间皮瘤的临床前测试
7. 361 A randomised open-label phase I/II study adding ONCOS-102 to pemetrexed/cisplatin in patients with unresectable malignant pleural mesothelioma – 12 month analysis of biomarkers and clinical outcomes [O] . Magnus Jaderberg, Susana Cedres, Luis Paz-Ares, 2020

机译：361 A随机开放标签I / II研究将ONCOS-102添加到患有不可切除的恶性胸膜间皮瘤患者中的Pemetrexed / Cisplatin - 12个月分析生物标志物和临床结果
8. Pre-Clinical Studies of Dendritic Cell-Tumor Cell Fusion Vaccines to Treat Breast Cancer. [R] . Akporiaye, E., Trevor, K. T. 2002

机译：树突状细胞 - 肿瘤细胞融合疫苗治疗乳腺癌的临床前研究。

Anti-tumor potency of cancer vaccine ONCOS-102 in the treatment of malignant mesothelioma in pre-clinical and clinical studies

著录项

相似文献

相关主题

期刊订阅